High Grade Glioma Glioblastoma clinical trials

Explore recruiting high grade glioma glioblastoma clinical trials.

Recruiting high grade glioma glioblastoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

High Grade Glioma Glioblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An interventional, multicenter, and international phase 1/2, light-dose-escalation study to investigate the safety and feasibility of intraoperative photodynamic therapy (PDT) with Pentalafen® drug and Heliance® Solution device in male and female patients 18 to 75 years of age with grade IV glioblastoma.

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

High Grade Glioma Glioblastoma trials by city

High Grade Glioma Glioblastoma clinical trials

Recruiting high grade glioma glioblastoma studies right now

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Sitagliptin in Recurrent/Progressive Grade 4 Glioma

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

A Study of 177Lu-PSMA-617 in People With Gliomas

Extensive Resection of Malignant Brain Tumors Using Advanced Imaging Techniques

Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Also recruiting in Europe

High Grade Glioma Glioblastoma trials by city

Other conditions